Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
2013 · Nature Genetics · 207 citations
https://doi.org/10.1038/ng.2652
M
Mark Liebow
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
120
Papers
3.7K
Citations
34
h-index
51
i10-index
Mark Liebow is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Genetic factors in colorectal cancer. The author has an h-index of 34, co-authored 102 publications.
ORCID: 0000-0002-4044-3709Papers by this author
worksAnalysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types
2015 · JNCI Journal of the National Cancer Institute · 189 citations
https://doi.org/10.1093/jnci/djv279
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
2017 · Nature Communications · 101 citations
https://doi.org/10.1038/ncomms14175
A genome-wide association study of marginal zone lymphoma shows association to the HLA region
2015 · Nature Communications · 68 citations
https://doi.org/10.1038/ncomms6751
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis
2009 · British Journal of Cancer · 49 citations
https://doi.org/10.1038/sj.bjc.6605284
History of autoimmune conditions and lymphoma prognosis
2018 · Blood Cancer Journal · 38 citations
https://doi.org/10.1038/s41408-018-0105-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat